Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It seems like they are ready for the run.
I support to take this action.
So what now, North or south? When will ELTP reach dollar land or head to quarter land?
Someone could control the share price below 0.15 and benefit from it.
Why there is a mysterious force controlling the p/s under 10 cents no matter what?
Our CEO hints that ELTP is not for sale until at least it is on NASDAQ.
It’s obvious that the manufacturing of products are running at least two work shifts to meet the demands.
I support our ceo and will vote yes!
Added some more these two days, have confidence with the company and the products.
What happened? ELTP starts jumping now?
What is cooking?
I bought more at 0.087 today. Been accumulating whenever there was a significant pullback.
Where is the phone?
Yummy yummy, why jumping so much today?
What happened? Where is the volume?
This is the best Nasrat and the company could do so far. My bet is the company will go forward, and we will be successful.
Added some more today.
Yummy, and thank you for the one who sold shares to me last Friday.
It makes sense to me that the cc will be better after the report released though.
It could be like this: The receivable should have become revenue by then, better hold on to the meeting.
Where is Stockboy? The bell for 2cents is ringing again, isn’t it?!
According to the company news, there is no number given out yet, why the stock was down over 30%?!
Bought more just before closing.
Great post!
Great!!!
Step by step moving forward 2 cents, correct?
It seems like they could not collect the money.
VANCOUVER, British Columbia, October 16, 2018 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, announces that it has decided to restate certain financial information reported for the quarter ended March 31, 2018.
The decision to restate followed a review conducted by the Company’s auditor and Audit Committee, wherein it was determined that the timing and certainty of receiving the revenue invoiced to clients is substantially unclear, due to clients’ issues with securing reimbursement from the payor.
The material changes to be included in the restatement will affect the Company’s revenue and are projected to increase the Company’s loss and comprehensive loss for Fiscal Year 2018. In addition, the Company’s Board of Directors have taken the position that no revenue will be reported for Q4 of fiscal 2018 until revenue collection issues are resolved.
“It is unfortunate that there has been such a steep learning curve for both Reliq and our clients in South Texas in terms of the claims submission process, but we have been working hard to address this issue and improve revenue collection going forward,” said Dr. Lisa Crossley, CEO of Reliq Health. “Many of the challenges the Company has faced in South Texas relate to the highly manual nature of the current clients’ internal processes. We are building out new capabilities in our platform to help automate the critical components of these processes, including eligibility screening, creation and approval of care plans and billing code selection. Management expects to have all of the necessary tools in place later this quarter to allow the company to move forward successfully.”
The Company will issue restated Q3 interim financial statements upon the completion of the June 30, 2018 audit, which will be filed on October 29, 2018.
The Company will hold its regularly scheduled quarterly call on October 30, 2018.
Conference Call Information:
When: October 30, 2018, 8:00am – 9:00am PST / 11:00am – noon EST
ID: 7857049
Dial In: Canada and U.S. – (844) 461-9931
International – (636) 812-6630
The Company would like to advise participants to join the conference call at least 10 minutes early in order to register. The Company’s CEO and CFO will present a slide deck which will be available by webinar (details to follow) and on the Reliq Health website as of 8:00am PST / 11:00am EST on October 30th, following which the moderator will open up the call to questions from investors who have registered and joined the queue. To join the queue participants will be asked to key in *1 at any point in the call. The moderator will open the line to callers in the queue one at a time in order of priority. A recording of the conference call will be available afterwards until November 6, 2018 and will be accessible by calling either of the following numbers: (855) 859-2056 or (404) 537-3406.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
ABOUT RELIQ HEALTH
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
For further information contact:
Investor Relations at Reliq Health or IR@reliqhealth.com
What is going on?Down so much today
Hi, boy: Is 2 cents really on its way?
Let’s be patient, it works out in accordance with their schedule. Do not bark on every adds and odds.
This is a profitable company, why the volume is so low?
Great, very informative and promising.
Encouraging!!
Is there a possibility that SOX been stuck could be a Sino-US political issue?
Great DD
Dealing with the government, one should keep the mouth shut and tight until everything is clear. Nasrat is not a boy.
I did buy more today.
What is going on? Please share
Compared to your 2 cents, this non-sense is still very positive and possible. ELTP will receive INCENTIVE from FDA because SOX helps solving the opioid crisis.